Vacinação contra Hepatite B em indivíduos renais crônicos em tratamento hemodialítico

Lopes, Letícia Pimenta; Teles, Sheila Araujo; Romão, Elen Almeida; Toffano, Silmara Elaine Malaguti; Rocha, Deborah Ferreira Noronha de Castro; Gir, Elucir.
Rev. enferm. UERJ ; 22(3)mai.-jun. 2014. tab
Artigo Português | LILACS, BDENF - enfermagem (Brasil) | ID: lil-748599

Documentos relacionados

  1. A real world comparison of HepB (Engerix-B®) and HepB-CpG (Heplisav-B®) vaccine seroprotection in patients receiving maintenance dialysis.
  2. [Immunity persistence of 60 µg high dose hepatitis B vaccine and influencing factors in maintained hemodialysis patients].
  3. Two-year immune effect differences between the 0-1-2-month and 0-1-6-month HBV vaccination schedule in adults.
  4. Timing of primary three-dose hepatitis B vaccination and postvaccination serologic testing among a large cohort of healthy adults.
  5. Immune response to hepatitis B vaccination and factors associated with poor immune response among healthcare workers.
  6. Longitudinal mapping of hepatitis B vaccine-induced B-cell linear epitopes in healthy individuals.
  7. Horizontal transmission might be a common route of hepatitis B virus exposure in highly endemic areas.
  8. Efficacy of an accelerated double-dose hepatitis B vaccine regimen in patients with cirrhosis.
  9. Duration of immunogenicity of high-dose and prolonged-schedule hepatitis B vaccine among patients with chronic kidney disease: A one year follow-up study in China.
  10. EVALUATION OF SOME BIOCHEMICAL MARKERS AND THE ANTIBODY RESPONSE TO HEPATITIS B VACCINE IN HEMODIALYSIS PATIENTS.